This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Christopher, S. A. Articles by Kruger, W. D. Search for Related Content PubMed PubMed Citation Articles by Christopher, S. A. Articles by Kruger, W. D.

Methylthioadenosine Phosphorylase, a Gene Frequently Codeleted with p16^cdkN2a/ARF, Acts as a Tumor Suppressor in a Breast Cancer Cell Line¹

Fox Chase Cancer Center, Division of Population Science, Philadelphia, Pennsylvania 19111 [S. A. C., W. D. K.], and Roswell Park Cancer Institute, Pharmacology and Therapeutics Department, Buffalo, New York 14263 [P. D., C. W. P.]

The human methylthioadenosine phosphorylase (MTAP) gene is located on 9p21 and is frequently homozygously deleted, along with p16^cdkN2a/ARF, in a wide variety of human tumors and human tumor-derived cell lines. The function of MTAP is to salvage methylthioadenosine, which is produced as a byproduct of polyamine metabolism. We have reintroduced MTAP into MCF-7 breast adenocarcinoma cells and have examined its effect on the tumorigenic properties of these cells. MTAP expression does not affect the growth rate of cells in standard tissue culture conditions but severely inhibits their ability to form colonies in soft agar or collagen. In addition, MTAP-expressing cells are suppressed for tumor formation when implanted into SCID mice. This suppression of anchorage-independent growth appears to be because of the enzymatic activity of MTAP, as a protein with a missense mutation in the active site does not exhibit this phenotype. MTAP expression causes a significant decrease in intracellular polyamine levels and alters the ratio of putrescine to total polyamines. Consistent with this observation, the polyamine biosynthesis inhibitor -difluoromethylornithine inhibits the ability of MTAP-deficient cells to form colonies in soft agar, whereas addition of the polyamine putrescine stimulates colony formation in MTAP-expressing cells. These results indicate that MTAP has tumor suppressor activity and suggest that its effects may be mediated by altering intracellular polyamine pools.

This article has been cited by other articles:

				H.-Y. Huang, S.-H. Li, S.-C. Yu, F.-F. Chou, C.-C. Tzeng, T.-H. Hu, Y.-H. Uen, Y.-F. Tian, Y.-H. Wang, F.-M. Fang, et al. Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors Clin. Cancer Res., November 15, 2009; 15(22): 6963 - 6972. [Abstract] [Full Text] [PDF]

				Y. Kadariya, B. Yin, B. Tang, S. A. Shinton, E. P. Quinlivan, X. Hua, A. Klein-Szanto, T. I. Al-Saleem, C. H. Bassing, R. R. Hardy, et al. Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase (MTAP) Die Prematurely of T-Cell Lymphoma Cancer Res., July 15, 2009; 69(14): 5961 - 5969. [Abstract] [Full Text] [PDF]

				I. Basu, G. Cordovano, I. Das, T. J. Belbin, C. Guha, and V. L. Schramm A Transition State Analogue of 5'-Methylthioadenosine Phosphorylase Induces Apoptosis in Head and Neck Cancers J. Biol. Chem., July 20, 2007; 282(29): 21477 - 21486. [Abstract] [Full Text] [PDF]

				S. Hirasaki, T. Noguchi, K. Mimori, J. Onuki, K. Morita, H. Inoue, K. Sugihara, M. Mori, and T. Hirano BAC Clones Related to Prognosis in Patients with Esophageal Squamous Carcinoma: An Array Comparative Genomic Hybridization Study Oncologist, April 1, 2007; 12(4): 406 - 417. [Abstract] [Full Text] [PDF]

				D. M. Kokkinakis, A. G. Brickner, J. M. Kirkwood, X. Liu, J. E. Goldwasser, A. Kastrama, C. Sander, D. Bocangel, and S. Chada Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress Mol. Cancer Res., August 1, 2006; 4(8): 575 - 589. [Abstract] [Full Text] [PDF]

				S. Marce, O. Balague, L. Colomo, A. Martinez, S. Holler, N. Villamor, F. Bosch, G. Ott, A. Rosenwald, L. Leoni, et al. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin. Cancer Res., June 15, 2006; 12(12): 3754 - 3761. [Abstract] [Full Text] [PDF]

				P. J. Wild, S. Meyer, F. Bataille, M. Woenckhaus, M. Ameres, T. Vogt, M. Landthaler, A. Pauer, M. Klinkhammer-Schalke, F. Hofstaedter, et al. Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol, April 1, 2006; 142(4): 471 - 476. [Abstract] [Full Text] [PDF]

				M. J. Worsham, K. M. Chen, N. Tiwari, G. Pals, J. P. Schouten, S. Sethi, and M. S. Benninger Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, April 1, 2006; 132(4): 409 - 415. [Abstract] [Full Text] [PDF]

				C. Hellerbrand, M. Muhlbauer, S. Wallner, M. Schuierer, I. Behrmann, F. Bataille, T. Weiss, J. Scholmerich, and A.-K. Bosserhoff Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma Carcinogenesis, January 1, 2006; 27(1): 64 - 72. [Abstract] [Full Text] [PDF]

				M. K. Chattopadhyay, C. W. Tabor, and H. Tabor Studies on the regulation of ornithine decarboxylase in yeast: Effect of deletion in the MEU1 gene PNAS, November 8, 2005; 102(45): 16158 - 16163. [Abstract] [Full Text] [PDF]

				L. Wang, X. Chen, B. Tang, X. Hua, A. Klein-Szanto, and W. D. Kruger Expression of mutant human cystathionine {beta}-synthase rescues neonatal lethality but not homocystinuria in a mouse model Hum. Mol. Genet., August 1, 2005; 14(15): 2201 - 2208. [Abstract] [Full Text] [PDF]

				A. L. Subhi, B. Tang, B. R. Balsara, D. A. Altomare, J. R. Testa, H. S. Cooper, J. P. Hoffman, N. J. Meropol, and W. D. Kruger Loss of Methylthioadenosine Phosphorylase and Elevated Ornithine Decarboxylase Is Common in Pancreatic Cancer Clin. Cancer Res., November 1, 2004; 10(21): 7290 - 7296. [Abstract] [Full Text] [PDF]

				M. Bumann, S. Djafarzadeh, A. E. Oberholzer, P. Bigler, M. Altmann, H. Trachsel, and U. Baumann Crystal Structure of Yeast Ypr118w, a Methylthioribose-1-phosphate Isomerase Related to Regulatory eIF2B Subunits J. Biol. Chem., August 27, 2004; 279(35): 37087 - 37094. [Abstract] [Full Text] [PDF]

				L. Wang, K.-H. Jhee, X. Hua, P. M. DiBello, D. W. Jacobsen, and W. D. Kruger Modulation of Cystathionine {beta}-Synthase Level Regulates Total Serum Homocysteine in Mice Circ. Res., May 28, 2004; 94(10): 1318 - 1324. [Abstract] [Full Text] [PDF]

				S. Kazemi, S. Papadopoulou, S. Li, Q. Su, S. Wang, A. Yoshimura, G. Matlashewski, T. E. Dever, and A. E. Koromilas Control of {alpha} Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2{alpha}) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2{alpha}-Dependent Gene Expression and Cell Death Mol. Cell. Biol., April 15, 2004; 24(8): 3415 - 3429. [Abstract] [Full Text] [PDF]

				A. L. Subhi, P. Diegelman, C. W. Porter, B. Tang, Z. J. Lu, G. D. Markham, and W. D. Kruger Methylthioadenosine Phosphorylase Regulates Ornithine Decarboxylase by Production of Downstream Metabolites J. Biol. Chem., December 12, 2003; 278(50): 49868 - 49873. [Abstract] [Full Text] [PDF]

				I. Behrmann, S. Wallner, W. Komyod, P. C. Heinrich, M. Schuierer, R. Buettner, and A.-K. Bosserhoff Characterization of Methylthioadenosin Phosphorylase (MTAP) Expression in Malignant Melanoma Am. J. Pathol., August 1, 2003; 163(2): 683 - 690. [Abstract] [Full Text] [PDF]

				A H Prowse, D C Schultz, S Guo, L Vanderveer, J Dangel, B Bove, P Cairns, M Daly, and A K Godwin Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred J. Med. Genet., August 1, 2003; 40(8): e102 - 102. [Full Text] [PDF]